OCALA, Fla. – There’s a new COVID-19 drug in town and the company behind it hopes the treatment will help those suffering from post-COVID-19 infection chronic fatigue-like symptoms, who have been dubbed “long haulers.”AIM ImmunoTech Inc.
announced Wednesday that they officially provide the first dose to their first patient with the drug called Ampligen.[TRENDING: How to get vaccine in Fla. | Publix to offer vaccine | Man sends dead rat to ex-wife | Dr.
Dre suffers brain aneurysm]The company believes this to be the first clinical trial to treat a patient with COVID-19-induced chronic fatigue-like symptoms.“AIM is committed to helping the untold number of people who are already dealing with the long-term effects of COVID-19 infection,” AIM.